MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience Long Term Debt Current 2011-2026 | VIVO
Annual Long Term Debt Current Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.83 M | 1.99 M | 1.79 M | - | 5.25 M | 4.5 M | 3.75 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.25 M | 1.79 M | 3.18 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
719 K | $ 14.1 | -3.46 % | $ 1.83 B |  USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
5.76 M | $ 13.29 | -1.88 % | $ 3.77 B | USA |
 |
Soleno Therapeutics
SLNO
|
726 K | $ 29.99 | -5.78 % | $ 1.52 B | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |  Israel |
 |
Neuronetics
STIM
|
5.56 M | $ 1.44 | 8.27 % | $ 95 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 478.51 | -2.12 % | $ 180 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 45.31 | -3.08 % | $ 2.71 B | USA |
 |
Co-Diagnostics
CODX
|
838 K | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Waters Corporation
WAT
|
31.1 M | $ 292.64 | -2.64 % | $ 17.4 B | USA |
 |
National Research Corporation
NRC
|
451 K | $ 17.16 | -1.15 % | $ 384 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 158.44 | -4.05 % | $ 7.85 B | USA |
 |
Exagen
XGN
|
1.23 M | $ 2.67 | -4.3 % | $ 57.6 M | USA |
 |
Organovo Holdings
ONVO
|
521 K | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
96.9 K | $ 4.65 | 1.31 % | $ 2.5 M | USA |
 |
Personalis
PSNL
|
7.7 M | $ 6.68 | -8.76 % | $ 396 M | USA |
 |
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
383 K | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
61.9 M | $ 57.44 | -3.32 % | $ 4.32 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B |  Niderland |
 |
Celcuity
CELC
|
54 K | $ 110.97 | -3.34 % | $ 5.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
496 K | $ 6.54 | -0.38 % | $ 273 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 268.45 | 0.03 % | $ 22.3 B | USA |
 |
VolitionRx Limited
VNRX
|
222 K | $ 0.2 | 3.52 % | $ 19.2 M |  Singapore |
 |
Psychemedics Corporation
PMD
|
1.05 M | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
218 K | $ 26.48 | -2.65 % | $ 34.4 M | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 17.08 | -2.23 % | $ 910 M | USA |
 |
Quotient Limited
QTNT
|
3.45 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
43.1 M | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
45 K | - | 5.66 % | $ 22.7 M |  Britain |